v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Cash Flow from Operating Activities:            
Net loss       $ (19,135) $ (6,851)  
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation and amortization       (46) 309  
Non-cash fixed assets adjustment       75  
Bargain purchase gain   $ (1,693) (1,693)  
Gain on disposal of assets, net       (13)  
Share-based compensation       961 2,032  
Debt discount amortization       3,320  
Equity offering-related parties       3,342  
Bad debt expense       (39)  
Income tax provision   6  
Change in fair value of digital assets 1,410   4,768  
Change in fair value of equity securities       481  
Change in fair value of derivative liabilities (578)   (1,170)  
Loss on settlement of debt (469) $ 3,100 2,588  
Other       (1) 2  
Changes in operating assets and liabilities:            
Accounts receivable, net       355 460  
Inventories, net       (533) 624  
Prepaid expenses and other assets       (1,417) (773)  
Accounts payable       (870) (594)  
Accrued liabilities       165 1,369  
Cash Used in Operating Activities       (10,505) (1,773)  
Cash Flow from Investing Activities:            
Acquisition of EMJX       (306)  
Short-term investments, net       (7,502)  
Purchase of digital assets     (16,468)  
Proceeds from sale of digital assets       9,580  
Purchase of equity securities       (5,240)  
Proceeds from sale of equities and option contracts (active trades)       159,200  
Purchases of equities and option contracts (active trades)       (158,575)  
Purchase of convertible note receivable       (6,377)  
Cash paid to SRx Canada       (3,400)  
Proceeds from sale of convertible note receivable       1,500  
Cash Used in Investing Activities       (24,188) (3,400)  
Cash Flow from Financing Activities:            
Proceeds from issuance of common stock       80,335  
Proceeds from issuance of convertible preferred stock       13,440  
Redemption of Series A convertible preferred stock       (21,773)  
Repayment of convertible debt       (1,623)  
Cash paid for financing costs       (625)  
Proceeds from warrant exercises       323  
Repurchase of common stock       (7)  
Proceeds from short-term borrowings       550  
Proceeds from Wintrust facility       859  
Payments on Wintrust facility       (1,662)  
Proceeds from PIPE       8,800  
PIPE out       (8,800)  
Payments for share repurchase       (137)  
Cash Provided by (Used in) Financing Activities       70,070 (390)  
Net cash provided by (used in) continuing operations       35,377 (5,563)  
Net cash provided by discontinued operations       6,253  
Net increase in cash and cash equivalents       35,377 690  
Effect of foreign currency translation adjustments       116  
Total cash and cash equivalents, beginning of period   $ 1,309   1,309 106 $ 106
Total cash and cash equivalents, end of period $ 36,686   $ 912 36,686 912 $ 1,309
Supplemental schedule of cash flow information:            
Cash paid for interest        
Disclosure of non-cash financing activities:            
Convertible note settled via reduction in equity consideration       $ 1,705